Product Images Gabapentin

This is a chart showing the mean pain scores during a 4-week dose titration period and a 4-week fixed dose period for a placebo group and a group taking 3600 mg/day of Gabapentin. The pain scores are rated on a scale of 0-10 and are plotted over a period of 4 weeks. There is no additional information available.*

This text appears to be a chart or table showing the number of weeks, dosage, and pain score measurements for a study involving a placebo and two doses of gabapentin. The first column shows the week of the study, the second column shows the dose given (either placebo or gabapentin at 1800mg or 2400mg per day), and the third column shows the mean pain score. Additional information is not available.*

The given text seems to be a statistical figure of certain studies conducted on patients suffering from chronic nerve pain. The figure illustrates the percentage of responders, i.e., patients who reported a reduction of more than 50% in their pain score after the treatment. The studies were performed with two different drugs, GBP 3600 and GBP 1800, along with a placebo. The text also indicates that some data are missing, and there is some analysis done to compare the results of these studies. However, without further context or information, it is difficult to provide a more specific description.*

This is a description of a prescription drug called "Neurontin 300mg (CV)" in capsule form. It is packaged by a company called "Bryant Ranck Prepack" and is being compared to a similar product made by "Granules India Limited". The pack contains 90 capsules and has an expiration date of MM/YY. The NDC number of the drug is 7133520041. Storage information is provided, advising to store the drug at room temperature of 20°-25°C (68°-77°F). The drug is only available with a prescription and should be kept out of reach of children. The has also captured a long number at the end which is most likely a product code.*